In the training of top qualified scientists for the future to work in universities, industry and the community, the Biozentrum emphasizes a strong research orientation and the close guidance of its students.

In its research, the Biozentrum incorporates the benefits of being international, interdisciplinary and innovative along with having leading-edge technology and highly qualified and motivated employees.

The Biozentrum of the University of Basel is one of the worldwide leading institutes for molecular and biomedical basic research and teaching.

Architecture of cellular control center mTORC2 elucidated

The protein complex mTORC2 controls cellular lipid and carbohydrate metabolism. Researchers from the Biozentrum of the University of Basel and the ETH Zurich have now succeeded in deciphering the 3D structure of this important protein complex. The results have recently been published in "eLife". more

Marek Basler receives renowned Friedrich Miescher Award

Prof. Marek Basler from the Biozentrum at the University of Basel and Prof. Paola Picotti from the ETH Zurich have been selected to receive the Friedrich Miescher Award 2018. This prize is Switzerland's highest distinction for young scientists working in the field of biochemistry. more

T3 Pharma qualifies for BaseLaunch funding program

T3 Pharmaceuticals, a spin-off from the Biozentrum of the University of Basel, has been selected for the second phase of the BaseLaunch start-up funding program. The biopharmaceutical company develops novel therapies for the treatment of cancer. more

International PhD Program

  • Application deadline June 20th, 2018. Weblink